Macrophage activation syndrome after etanercept treatment [14]

Journal of Rheumatology

Volumn 34, Issue 1, 2007, Pages 241-242

  Sandhu, Charanjit ^a   Chesney, Alden ^b   Piliotis, Eugenia ^b   Buckstein, Rena ^b   Koren, Sharon ^b  

^a ST MICHAEL'S HOSPITAL   (Canada)

^b SUNNYBROOK RESEARCH INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; DEXAMETHASONE; ETANERCEPT; IMMUNOGLOBULIN;

ADULT; AUTOIMMUNE DISEASE; BONE MARROW BIOPSY; CASE REPORT; CLINICAL FEATURE; DISEASE COURSE; DRUG WITHDRAWAL; FEMALE; FEVER; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOSUPPRESSIVE TREATMENT; IN SITU HYBRIDIZATION; LABORATORY TEST; LETTER; LIVER FUNCTION TEST; MACROPHAGE ACTIVATION SYNDROME; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SIDE EFFECT; SYMPTOMATOLOGY;

ADULT; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; BONE MARROW; FEMALE; HUMANS; IMMUNOGLOBULIN G; LYMPHOHISTIOCYTOSIS, HEMOPHAGOCYTIC; MACROPHAGE ACTIVATION; RECEPTORS, TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33846250466     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (10)

1. Ravelli A. Macrophage activation syndrome. Curr Opin Rheumatol 2002;14:548-52.
2. Schneider R, Laxer RM. Systemic onset juvenile rheumatoid arthritis. Baillieres Clin Rheumatol 1998;12:245-71.
3. Emmenegger U, Schaer DJ, Larroche C, Neftel KA. Haemophagocytic syndromes in adults: current concepts and challenges ahead. Swiss Med Wkly 2005;135:299-314.
4. Dhote R, Simon J, Papo T, et al. Reactive hemophagocytic syndrome in adult systemic disease: report of twenty-six cases and literature review. Arthritis Rheum 2003;49:633-9.
5. Reiner AP, Spivak JL. Hematophagic histiocytosis. A report of 23 new patients and a review of the literature. Medicine Baltimore 1988;67:369-88.
6. Ramanan AV, Schneider R. Macrophage activation syndrome following initiation of etanercept in a child with systemic onset juvenile rheumatoid arthritis. J Rheumatol 2003;30:401-3.
7. Henter JI, Tondini C, Pritchard J. Histiocyte disorders. Crit Rev Oncol Hematol 2004;50:157-74.
8. Henter JI, Samuelsson-Horne A, Arico M, et al. Treatment of hemophagocytic lymphohistiocytosis with HLH-94 immunochemotherapy and bone marrow transplantation. Blood 2002;100:2367-73.
9. Larroche C, Bruneel F, Andre MH, et al. Intravenously administered gamma-globulins in reactive hemophagocytic syndrome. Multicenter study to assess their importance, by the immunoglobulins group of experts of CEDIT of the AP-HP [French], Ann Med Interne (Paris) 2000;151:533-9.
10. Hadchouel M, Prieur AM, Griscelli C. Acute hemorrhagic, hepatic, and neurologic manifestations in juvenile rheumatoid arthritis: possible relationship to drugs or infection. J Pediatr 1985;106:561-6.